文献速递中医内科中药与中成药合理使用

连接中医与阿尔茨海默病:肠道菌群在多靶点治疗机制中的关键作用

Bridging traditional Chinese medicine and Alzheimer's disease: the pivotal role of gut microbiota in multitarget therapeutic mechanisms.
PubMed 文献 · Front Pharmacol · 2025-06-27

本文综述肠道菌群在阿尔茨海默病(AD)发病中的作用,以及中药通过调节肠道菌群干预AD的潜在机制与临床应用前景。文章指出中药多靶点优势与肠道菌群作为介导和靶点的双重角色,为中药治疗AD提供新理论基础。

要点

  • 肠道菌群通过免疫、代谢、消化和神经功能影响AD病理。
  • 中药多靶点作用可能通过调节肠道菌群干预AD。
  • 肠道菌群既是中药作用的介导者也是治疗靶点。

核心结论

  • 中药可能通过调节肠道菌群发挥多靶点治疗AD的潜力,但机制尚待阐明。

研究设计与样本

  • 综述类文章,检索范围未明确报告。

主要发现

  • 肠道菌群通过调节免疫、代谢、消化和神经功能影响AD病理。
  • 中药在摄入、吸收和治疗作用过程中,肠道菌群既是介导者也是治疗靶点。
  • 中药与肠道菌群交互作用对AD有益效应的机制尚不明确。

临床怎么用

  • 文章为中药调节肠道菌群治疗AD的研究提供理论依据和方法学支持。

局限性

  • 中药与肠道菌群交互作用对AD有益效应的机制尚不明确。
  • 通过肠道菌群干预治疗AD的研究虽有进展,但实质性突破仍有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Microbiota-gut-brain axis communication represents another crucial pathway in the pathogenesis of Alzheimer's disease (AD), whereby gut microbiota significantly impacts AD pathology by modulating immune, metabolic, digestive, and neurological functions. Although research on treating AD through gut microbiota interventions is advancing, substantial breakthroughs remain limited. Given AD's complex pathological mechanisms, Traditional Chinese Medicine (TCM) presents a clear advantage with its multi-target effects. During the processes of TCM intake, absorption, and therapeutic action, the gut microbiota serves both as a mediator and as a therapeutic target. However, the mechanisms by which TCM interacts with gut microbiota to exert beneficial effects on AD remain largely unclarified. Here, we review the mechanisms through which TCM may intervene in AD from the perspective of gut microbiota, examining the potential mechanisms and clinical application prospects of Chinese herbal medicine in regulating the gut microbiome. This provides a novel theoretical foundation and methodological support for further research into herbal therapies for AD.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Wu W, Meng T, Han L, et al. Bridging traditional Chinese medicine and Alzheimer's disease: the pivotal role of gut microbiota in multitarget therapeutic mechanisms. Front Pharmacol. 2025. PMID: 40657642. doi:10.3389/fphar.2025.1630205

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。